FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,026,000 | -10.9% | 46,386 | -15.3% | 0.23% | -14.7% |
| Q1 2021 | $4,518,000 | +268.2% | 54,795 | +306.0% | 0.27% | +272.6% |
| Q4 2020 | $1,227,000 | -25.8% | 13,497 | -67.4% | 0.07% | -40.7% |
| Q3 2020 | $1,654,000 | +103.7% | 41,400 | +13.2% | 0.12% | +64.0% |
| Q1 2020 | $812,000 | -93.5% | 36,564 | -94.2% | 0.08% | -91.6% |
| Q4 2019 | $12,430,000 | +109.8% | 635,143 | +66.4% | 0.90% | +67.2% |
| Q3 2019 | $5,926,000 | +65.5% | 381,600 | +87.3% | 0.54% | +55.4% |
| Q1 2019 | $3,581,000 | +21.5% | 203,742 | -11.3% | 0.34% | -6.0% |
| Q4 2018 | $2,948,000 | +72.5% | 229,813 | +119.1% | 0.37% | +141.4% |
| Q3 2018 | $1,709,000 | – | 104,891 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |